C12Y 207/08015
Udp-n-acetylglucosamine--dolichyl-phosphate n-acetylglucosaminephosphotransferase
Official title: UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase (2.7.8.15)
C12Y207/08015 (Udp-n-acetylglucosamine--dolichyl-phosphate n-acetylglucosaminephosphotransferase) appears on 5 US grants and 9 published applications in this corpus.
Search patents in C12Y- Granted patents
- 5
- Published applications
- 9
- Assignees
- 3
- Inventors
- 6
- Latest grant
- 1 Oct 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2014 | 0 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 0 |
| 2018 | 0 | 2 |
| 2019 | 1 | 1 |
| 2020 | 1 | 1 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 1 | 1 |
| 2025 | 0 | 2 |
By publication year.
Recent patents
- Cleavable lipids1 Oct 2024US 12,102,720 B2Translate Bio, Inc.
- Cleavable lipids1 Feb 2022US 11,234,936 B2Translate Bio, Inc.
- Cleavable lipids7 Jul 2020US 10,702,478 B2Translate Bio, Inc.
- Cleavable lipids17 Dec 2019US 10,507,183 B2Translate Bio, Inc.
- Cleavable lipids1 Aug 2017US 9,717,690 B2RaNA Therapeutics, Inc.
- Lyophilized Pharmaceutical Compositions Comprising A Lipid Nanoparticle22 May 2025US 2025/0161221 A1Translate Bio, Inc.
- Compositions comprising glucocerebrocidase and methods of use thereof15 May 2025US 2025/0152680 A1
- Lyophilized Pharmaceutical Compositions Comprising a Lipid Nanoparticle12 Dec 2024US 2024/0408020 A1Translate Bio, Inc.
- Cleavable Lipids30 Jun 2022US 2022/0202718 A1Translate Bio, Inc.
- Cleavable Lipids30 Jul 2020US 2020/0237671 A1Translate Bio, Inc.
Most cited
By later US patents